ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ICHR • KYG4740B1059

34.11 USD
+1.96 (+6.1%)
At close: Feb 9, 2026
42.3988 USD
+8.29 (+24.3%)
After Hours: 2/9/2026, 8:07:19 PM
Fundamental Rating

3

Taking everything into account, ICHR scores 3 out of 10 in our fundamental rating. ICHR was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. While ICHR seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ICHR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • ICHR had positive earnings in the past year.
  • ICHR had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ICHR reported negative net income in multiple years.
  • Each year in the past 5 years ICHR had a positive operating cash flow.
ICHR Yearly Net Income VS EBIT VS OCF VS FCFICHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

  • ICHR has a worse Return On Assets (-4.22%) than 63.72% of its industry peers.
  • ICHR has a Return On Equity of -6.03%. This is in the lower half of the industry: ICHR underperforms 62.83% of its industry peers.
Industry RankSector Rank
ROA -4.22%
ROE -6.03%
ROIC N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ICHR Yearly ROA, ROE, ROICICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • ICHR's Gross Margin of 9.80% is on the low side compared to the rest of the industry. ICHR is outperformed by 85.84% of its industry peers.
  • ICHR's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ICHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
ICHR Yearly Profit, Operating, Gross MarginsICHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

4

2. Health

2.1 Basic Checks

  • ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ICHR has more shares outstanding
  • Compared to 5 years ago, ICHR has more shares outstanding
  • Compared to 1 year ago, ICHR has an improved debt to assets ratio.
ICHR Yearly Shares OutstandingICHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ICHR Yearly Total Debt VS Total AssetsICHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 3.75 indicates that ICHR is not in any danger for bankruptcy at the moment.
  • ICHR has a Altman-Z score (3.75) which is in line with its industry peers.
  • ICHR has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • ICHR has a Debt to Equity ratio of 0.17. This is comparable to the rest of the industry: ICHR outperforms 49.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 3.75
ROIC/WACCN/A
WACC10.93%
ICHR Yearly LT Debt VS Equity VS FCFICHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 3.08 indicates that ICHR has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.08, ICHR is in line with its industry, outperforming 53.10% of the companies in the same industry.
  • ICHR has a Quick Ratio of 1.33. This is a normal value and indicates that ICHR is financially healthy and should not expect problems in meeting its short term obligations.
  • ICHR has a worse Quick ratio (1.33) than 78.76% of its industry peers.
Industry RankSector Rank
Current Ratio 3.08
Quick Ratio 1.33
ICHR Yearly Current Assets VS Current LiabilitesICHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 1400.00% over the past year.
  • The earnings per share for ICHR have been decreasing by -33.82% on average. This is quite bad
  • Looking at the last year, ICHR shows a quite strong growth in Revenue. The Revenue has grown by 16.86% in the last year.
  • Measured over the past years, ICHR shows a small growth in Revenue. The Revenue has been growing by 6.46% on average per year.
EPS 1Y (TTM)1400%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-41.67%
Revenue 1Y (TTM)16.86%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%13.34%

3.2 Future

  • Based on estimates for the next years, ICHR will show a very strong growth in Earnings Per Share. The EPS will grow by 73.41% on average per year.
  • ICHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.33% yearly.
EPS Next Y7.92%
EPS Next 2Y124.01%
EPS Next 3Y116.19%
EPS Next 5Y73.41%
Revenue Next Year11.36%
Revenue Next 2Y8.83%
Revenue Next 3Y9.72%
Revenue Next 5Y10.33%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ICHR Yearly Revenue VS EstimatesICHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
ICHR Yearly EPS VS EstimatesICHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 113.70, the valuation of ICHR can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as ICHR.
  • Compared to an average S&P500 Price/Earnings ratio of 28.06, ICHR is valued quite expensively.
  • ICHR is valuated quite expensively with a Price/Forward Earnings ratio of 42.48.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ICHR is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.86, ICHR is valued quite expensively.
Industry RankSector Rank
PE 113.7
Fwd PE 42.48
ICHR Price Earnings VS Forward Price EarningsICHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ICHR.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 239.32
ICHR Per share dataICHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as ICHR's earnings are expected to grow with 116.19% in the coming years.
PEG (NY)14.35
PEG (5Y)N/A
EPS Next 2Y124.01%
EPS Next 3Y116.19%

0

5. Dividend

5.1 Amount

  • ICHR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ICHOR HOLDINGS LTD

NASDAQ:ICHR (2/9/2026, 8:07:19 PM)

After market: 42.3988 +8.29 (+24.3%)

34.11

+1.96 (+6.1%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-03
Earnings (Next)02-09
Inst Owners98.06%
Inst Owner Change-0.91%
Ins Owners2.11%
Ins Owner Change19.13%
Market Cap1.17B
Revenue(TTM)957.34M
Net Income(TTM)-40.76M
Analysts78.46
Price Target30.75 (-9.85%)
Short Float %9.2%
Short Ratio4.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.69%
Min EPS beat(2)-79.27%
Max EPS beat(2)-42.12%
EPS beat(4)0
Avg EPS beat(4)-46.48%
Min EPS beat(4)-79.27%
Max EPS beat(4)-9.51%
EPS beat(8)2
Avg EPS beat(8)-601.07%
EPS beat(12)4
Avg EPS beat(12)-374.76%
EPS beat(16)6
Avg EPS beat(16)-280.24%
Revenue beat(2)1
Avg Revenue beat(2)0.11%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)0.45%
Revenue beat(4)1
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)0.45%
Revenue beat(8)4
Avg Revenue beat(8)-0.16%
Revenue beat(12)6
Avg Revenue beat(12)-0.3%
Revenue beat(16)8
Avg Revenue beat(16)-0.27%
PT rev (1m)26.47%
PT rev (3m)21.38%
EPS NQ rev (1m)2.48%
EPS NQ rev (3m)-284.49%
EPS NY rev (1m)0.85%
EPS NY rev (3m)-58.03%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 113.7
Fwd PE 42.48
P/S 1.22
P/FCF N/A
P/OCF 64.34
P/B 1.73
P/tB 3.93
EV/EBITDA 239.32
EPS(TTM)0.3
EY0.88%
EPS(NY)0.8
Fwd EY2.35%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)0.53
OCFY1.55%
SpS27.85
BVpS19.67
TBVpS8.68
PEG (NY)14.35
PEG (5Y)N/A
Graham Number11.52
Profitability
Industry RankSector Rank
ROA -4.22%
ROE -6.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.8%
FCFM N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
F-Score4
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 24.68
Cap/Depr 118.71%
Cap/Sales 3.9%
Interest Coverage N/A
Cash Conversion 383.91%
Profit Quality N/A
Current Ratio 3.08
Quick Ratio 1.33
Altman-Z 3.75
F-Score4
WACC10.93%
ROIC/WACCN/A
Cap/Depr(3y)62.01%
Cap/Depr(5y)61.74%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1400%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-41.67%
EPS Next Y7.92%
EPS Next 2Y124.01%
EPS Next 3Y116.19%
EPS Next 5Y73.41%
Revenue 1Y (TTM)16.86%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%13.34%
Revenue Next Year11.36%
Revenue Next 2Y8.83%
Revenue Next 3Y9.72%
Revenue Next 5Y10.33%
EBIT growth 1Y-86.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year211.09%
EBIT Next 3Y73.35%
EBIT Next 5Y50.15%
FCF growth 1Y-149.43%
FCF growth 3YN/A
FCF growth 5Y-22.51%
OCF growth 1Y-69.02%
OCF growth 3Y22.22%
OCF growth 5Y-13.37%

ICHOR HOLDINGS LTD / ICHR FAQ

What is the ChartMill fundamental rating of ICHOR HOLDINGS LTD (ICHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICHR.


Can you provide the valuation status for ICHOR HOLDINGS LTD?

ChartMill assigns a valuation rating of 2 / 10 to ICHOR HOLDINGS LTD (ICHR). This can be considered as Overvalued.


How profitable is ICHOR HOLDINGS LTD (ICHR) stock?

ICHOR HOLDINGS LTD (ICHR) has a profitability rating of 2 / 10.


What is the financial health of ICHOR HOLDINGS LTD (ICHR) stock?

The financial health rating of ICHOR HOLDINGS LTD (ICHR) is 4 / 10.